The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
John Ormiston
Showing 1-20 of 49 articles
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions
Verheye S,
Costa R,
Schofer J,
Ormiston J,
Maeng M,
Dudek D,
Skurk C,
Botelho R,
Costa J,
Chamié D,
Abizaid An,
Boersma E,
Abizaid A
October 18, 2019 | 10.4244/EIJ-D-18-00292
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y,
Onuma Y,
Asano T,
Chichareon P,
Collet C,
Miyazaki Y,
Piek J,
Wykrzykowska J,
Abizaid A,
Ormiston J,
Chevalier B,
Serruys P
October 12, 2018 | 10.4244/EIJ-D-18-00301
Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials
Wijns W,
Vrolix M,
Verheye S,
Schoors D,
Slagboom T,
Gosselink M,
Benit E,
Kandzar D,
Donohoe D,
Ormiston J
April 6, 2018 | 10.4244/EIJ-D-17-00230
It seemed like a good idea at the time
Ormiston J,
Webster M
March 20, 2018 | 10.4244/EIJV13I16A306
Bench testing and coronary artery bifurcations: a consensus document from the European Bifurcation Club
Ormiston J,
Kassab G,
Finet G,
Chatzizisis YS,
Foin N,
Mickley T,
Chiastra C,
Murasato Y,
Hikichi Y,
Wentzel J,
Darremont O,
Iwasaki K,
Lefèvre T,
Louvard Y,
Beier S,
Hojeibane H,
Netravali A,
Wooton J,
Cowan B,
Webster M,
Medrano-Gracia P,
Stankovic G
February 2, 2018 | 10.4244/EIJ-D-17-00270
Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study
Suwannasom P,
Sotomi Y,
Asano T,
Koon J,
Tateishi H,
Zeng Y,
Tenekecioglu E,
Wykrzykowska J,
Foin N,
de Winter R,
Ormiston J,
Serruys P,
Onuma Y
April 7, 2017 | 10.4244/EIJ-D-16-00740
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial
Iqbal J,
Verheye S,
Abizaid A,
Ormiston J,
De Vries T,
Morrison L,
Toyloy S,
Fitzgerald P,
Windecker S,
Serruys P
December 9, 2016 | 10.4244/EIJY15M10_04
A computational atlas of normal coronary artery anatomy
Medrano-Gracia P,
Ormiston J,
Webster M,
Beier S,
Young A,
Ellis C,
Wang C,
Smedby O,
Cowan B
September 18, 2016 | 10.4244/EIJV12I7A139
Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials
Wijns W,
Suttorp MJ,
Zagozdzon L,
Morice M,
McClean D,
Stella P,
Donohoe D,
Knape C,
Ormiston J
June 20, 2016 | 10.4244/EIJY15M09_14
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data
Bourantas C,
Serruys P,
Nakatani S,
Zhang Y-J,
Farooq V,
Diletti R,
Ligthart J,
Sheehy A,
van Geuns R,
McClean D,
Chevalier B,
Windecker S,
Koolen J,
Ormiston J,
Whitbourn R,
Rapoza R,
Veldhof S,
Onuma Y,
Garcia-Garcia H
November 20, 2015 | 10.4244/EIJY14M10_06
Lessons from the real bench: non-BRS
Ormiston J,
Darremont O,
Iwasaki K,
Murasato Y,
Hikichi Y,
Webber B,
Webster M
May 19, 2015 | 10.4244/EIJV11SVA6
Bioresorbable scaffolds on the bench
Ormiston J,
Motreff P,
Darremont O,
Webber B,
Guérin P,
Webster M
May 19, 2015 | 10.4244/EIJV11SVA40
The future of BRS in bifurcations
Kraak R,
Grundeken M.J,
Onuma Y,
Tu S,
Wykrzykowska J,
Chevalier B,
Ormiston J,
Serruys P
May 19, 2015 | 10.4244/EIJV11SVA45
An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition)
Ormiston J,
Webber B,
Ben Ubod B,
Darremont O,
Webster M
May 19, 2015 | 10.4244/EIJY15M02_03
Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial
Wijns W,
Vrolix M,
Verheye S,
Schoors D,
Slagboom T,
Gosselink M,
Benit E,
Donohoe D,
Knape C,
Attizzani G,
Lansky AJ,
Ormiston J
April 20, 2015 | 10.4244/EIJY14M05_03
Coronary stent durability and fracture: an independent bench comparison of six contemporary designs using a repetitive bend test
Ormiston J,
Webber B,
Ubod B,
White J,
Webster M
April 20, 2015 | 10.4244/EIJY14M11_08
Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial
Nakatani S,
Onuma Y,
Ishibashi Y,
Muramatsu T,
Iqbal J,
Zhang Y-J,
van Geuns R,
Ormiston J,
Serruys P
March 20, 2015 | 10.4244/EIJV10I11A218
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial
Bourantas C,
Farooq V,
Zhang Y-J,
Muramatsu T,
Gogas B,
Thuesen L,
McClean D,
Chevalier B,
Windecker S,
Koolen J,
Ormiston J,
Whitbourn R,
Dorange C,
Rapoza R,
Onuma Y,
Garcia-Garcia H,
Serruys P
March 20, 2015 | 10.4244/EIJY14M04_11
A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial
Sakata K,
Koo B,
Waseda K,
Nakatani D,
Yock P,
Whitbourn R,
Worthley S,
Ormiston J,
Webster M,
Wilkins G,
Honda Y,
Meredith I,
Fitzgerald P
March 20, 2015 | 10.4244/EIJY14M08_16
Absorb everolimus-eluting bioresorbable scaffolds in coronary bifurcations: a bench study of deployment, side branch dilatation and post-dilatation strategies
Ormiston J,
Webber B,
Ubod B,
Webster M,
White J
February 20, 2015 | 10.4244/EIJY14M05_08
1
2
3
Latest news
AHEAD OF PRINT
Catheter-directed thrombolysis in intermediate-high risk acute pulmonary embolism
FREE ARTICLE - Josef Kroupa et al
May 27, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke